Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Gratz, Silvia S.
Levinson, Douglas F.
and
Simpson, George M.
1992.
The treatment and management of neuroleptic malignant syndrome.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 16,
Issue. 4,
p.
425.
White, D. A. C.
1992.
Catatonia and the Neuroleptic Malignant Syndrome – a Single Entity?.
British Journal of Psychiatry,
Vol. 161,
Issue. 4,
p.
558.
Renwick, D. S
Chandraker, A.
and
Bannister, P.
1992.
Missed neuroleptic malignant syndrome: Authors' reply.
BMJ,
Vol. 304,
Issue. 6836,
p.
1246.
Fink, M.
1992.
Missed neuroleptic malignant syndrome..
BMJ,
Vol. 304,
Issue. 6836,
p.
1246.
Craddock, B.
and
Craddock, N.
1992.
Missed neuroleptic malignant syndrome..
BMJ,
Vol. 304,
Issue. 6836,
p.
1246.
White, A.
and
Everist, B.
1992.
Missed neuroleptic malignant syndrome..
BMJ,
Vol. 304,
Issue. 6836,
p.
1246.
Domken, M.-A.
and
Farquharson, R. G.
1992.
Catatonia and creatinine phosphokinase.
British Journal of Psychiatry,
Vol. 161,
Issue. 2,
p.
283.
Cunningham, D.
1992.
Myeloma and benign intracranial hypertension: Author's reply.
BMJ,
Vol. 304,
Issue. 6836,
p.
1245.
Wilhelm, Kay
Curtis, Jackie
Birkett, Virginia
and
Kenney-Herbert, Jeremy
1994.
The Clinical Significance of Serial Creatine Phosphokinase Estimations in Acute Ward Admissions.
Australian & New Zealand Journal of Psychiatry,
Vol. 28,
Issue. 3,
p.
453.
Aydin, N
Anaç, A
Çayköylü, A
and
Akçay, F
2001.
Reply: Citalopram Overdose, Serotonin Toxicity, or Neuroleptic Malignant Syndrome?.
The Canadian Journal of Psychiatry,
Vol. 46,
Issue. 7,
p.
658.
eLetters
No eLetters have been published for this article.